Alephoson Biopharmaceuticals Limited
PrivateLast Round
Series A
Jan 23, 2026
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alephoson Biopharmaceuticals Limited is a biotechnology company that develops innovative drug delivery technologies for ophthalmic diseases using its proprietary Cell Penetration Protein Alternation (CePPA) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alephoson Biopharmaceuticals Limited Comparables
Compare Alephoson Biopharmaceuticals Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 74% | |
| PhoreMost | 73% | |
| TheratOcular Biotek | 67% |
Alephoson Biopharmaceuticals Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 23, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
$10M round completed.
Alephoson Biopharmaceuticals Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alephoson Biopharmaceuticals Limited's valuation, stock price, and market status.
Is Alephoson Biopharmaceuticals Limited a public or private company?
Alephoson Biopharmaceuticals Limited is a private company.
What is the current stock price of Alephoson Biopharmaceuticals Limited?
Alephoson Biopharmaceuticals Limited is a private company, so its shares have no public market price. Caplight tracks Alephoson Biopharmaceuticals Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alephoson Biopharmaceuticals Limited worth (valuation)?
Valuation information for Alephoson Biopharmaceuticals Limited is not publicly available.
Can I buy Alephoson Biopharmaceuticals Limited stock?
Alephoson Biopharmaceuticals Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alephoson Biopharmaceuticals Limited's last funding round?
Alephoson Biopharmaceuticals Limited's most recent funding round was Series A on January 23, 2026.
Who are the main investors in Alephoson Biopharmaceuticals Limited?
Investor information for Alephoson Biopharmaceuticals Limited is not publicly disclosed.
Will Alephoson Biopharmaceuticals Limited IPO soon?
No public IPO plans have been announced for Alephoson Biopharmaceuticals Limited.
How can I track Alephoson Biopharmaceuticals Limited secondary market activity?
Caplight tracks bids, offers, and trades in Alephoson Biopharmaceuticals Limited's shares on secondary markets.